Index by author
October 01, 2017; Volume 363,Issue 1
A
Ali, Cherie
- You have accessNKTR-181: A Novel Mu-Opioid Analgesic with Inherently Low Abuse PotentialTakahiro Miyazaki, Irene Y. Choi, Werner Rubas, Neel K. Anand, Cherie Ali, Juli Evans, Hema Gursahani, Marlene Hennessy, Grace Kim, Daniel McWeeney, Juergen Pfeiffer, Phi Quach, David Gauvin, Timothy A. Riley, Jennifer A. Riggs, Kathleen Gogas, Jonathan Zalevsky and Stephen K. DobersteinJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 104-113; DOI: https://doi.org/10.1124/jpet.117.243030
Almon, Richard R.
- You have accessMechanistic Multi—Tissue Modeling of Glucocorticoid-Induced Leucine Zipper Regulation: Integrating Circadian Gene Expression with Receptor-Mediated Corticosteroid PharmacodynamicsVivaswath S. Ayyar, Debra C. DuBois, Richard R. Almon and William J. JuskoJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 45-57; DOI: https://doi.org/10.1124/jpet.117.242990
Anand, Neel K.
- You have accessNKTR-181: A Novel Mu-Opioid Analgesic with Inherently Low Abuse PotentialTakahiro Miyazaki, Irene Y. Choi, Werner Rubas, Neel K. Anand, Cherie Ali, Juli Evans, Hema Gursahani, Marlene Hennessy, Grace Kim, Daniel McWeeney, Juergen Pfeiffer, Phi Quach, David Gauvin, Timothy A. Riley, Jennifer A. Riggs, Kathleen Gogas, Jonathan Zalevsky and Stephen K. DobersteinJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 104-113; DOI: https://doi.org/10.1124/jpet.117.243030
Arsova, Angela
- You have accessCXCR4-Specific Nanobodies as Potential Therapeutics for WHIM syndromeRaymond H. de Wit, Raimond Heukers, Hendrik J. Brink, Angela Arsova, David Maussang, Pasquale Cutolo, Beatrijs Strubbe, Henry F. Vischer, Françoise Bachelerie and Martine J. SmitJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 35-44; DOI: https://doi.org/10.1124/jpet.117.242735
Ayyar, Vivaswath S.
- You have accessMechanistic Multi—Tissue Modeling of Glucocorticoid-Induced Leucine Zipper Regulation: Integrating Circadian Gene Expression with Receptor-Mediated Corticosteroid PharmacodynamicsVivaswath S. Ayyar, Debra C. DuBois, Richard R. Almon and William J. JuskoJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 45-57; DOI: https://doi.org/10.1124/jpet.117.242990
B
Bachelerie, Françoise
- You have accessCXCR4-Specific Nanobodies as Potential Therapeutics for WHIM syndromeRaymond H. de Wit, Raimond Heukers, Hendrik J. Brink, Angela Arsova, David Maussang, Pasquale Cutolo, Beatrijs Strubbe, Henry F. Vischer, Françoise Bachelerie and Martine J. SmitJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 35-44; DOI: https://doi.org/10.1124/jpet.117.242735
Bohnsack, John Peyton
- You have accessEthanol Exposure Regulates Gabra1 Expression via Histone Deacetylation at the Promoter in Cultured Cortical NeuronsJohn Peyton Bohnsack, Vraj K. Patel and A. Leslie MorrowJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 1-11; DOI: https://doi.org/10.1124/jpet.117.242446
Bolognese, Brian J.
- You have accessCharacterization of the Potent, Selective Nrf2 Activator, 3-(Pyridin-3-Ylsulfonyl)-5-(Trifluoromethyl)-2H-Chromen-2-One, in Cellular and In Vivo Models of Pulmonary Oxidative StressJohn G. Yonchuk, Joseph P. Foley, Brian J. Bolognese, Gregory Logan, William E. Wixted, Jen-Pyng Kou, Diana G. Chalupowicz, Heidi G. Feldser, Yolanda Sanchez, Hong Nie, James F. Callahan, Jeffrey K. Kerns and Patricia L. PodolinJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 114-125; DOI: https://doi.org/10.1124/jpet.117.241794
Brennan, C.H.
- You have accessAssessing the Value of the Zebrafish Conditioned Place Preference Model for Predicting Human Abuse PotentialA. J. Brock, S. M. G. Goody, A. N. Mead, A. Sudwarts, M.O. Parker and C.H. BrennanJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 66-79; DOI: https://doi.org/10.1124/jpet.117.242628
Brink, Hendrik J.
- You have accessCXCR4-Specific Nanobodies as Potential Therapeutics for WHIM syndromeRaymond H. de Wit, Raimond Heukers, Hendrik J. Brink, Angela Arsova, David Maussang, Pasquale Cutolo, Beatrijs Strubbe, Henry F. Vischer, Françoise Bachelerie and Martine J. SmitJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 35-44; DOI: https://doi.org/10.1124/jpet.117.242735
Brock, A. J.
- You have accessAssessing the Value of the Zebrafish Conditioned Place Preference Model for Predicting Human Abuse PotentialA. J. Brock, S. M. G. Goody, A. N. Mead, A. Sudwarts, M.O. Parker and C.H. BrennanJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 66-79; DOI: https://doi.org/10.1124/jpet.117.242628
C
Callahan, James F.
- You have accessCharacterization of the Potent, Selective Nrf2 Activator, 3-(Pyridin-3-Ylsulfonyl)-5-(Trifluoromethyl)-2H-Chromen-2-One, in Cellular and In Vivo Models of Pulmonary Oxidative StressJohn G. Yonchuk, Joseph P. Foley, Brian J. Bolognese, Gregory Logan, William E. Wixted, Jen-Pyng Kou, Diana G. Chalupowicz, Heidi G. Feldser, Yolanda Sanchez, Hong Nie, James F. Callahan, Jeffrey K. Kerns and Patricia L. PodolinJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 114-125; DOI: https://doi.org/10.1124/jpet.117.241794
Chalupowicz, Diana G.
- You have accessCharacterization of the Potent, Selective Nrf2 Activator, 3-(Pyridin-3-Ylsulfonyl)-5-(Trifluoromethyl)-2H-Chromen-2-One, in Cellular and In Vivo Models of Pulmonary Oxidative StressJohn G. Yonchuk, Joseph P. Foley, Brian J. Bolognese, Gregory Logan, William E. Wixted, Jen-Pyng Kou, Diana G. Chalupowicz, Heidi G. Feldser, Yolanda Sanchez, Hong Nie, James F. Callahan, Jeffrey K. Kerns and Patricia L. PodolinJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 114-125; DOI: https://doi.org/10.1124/jpet.117.241794
Chen, Ying
- You have accessEnhancing Studies of Pharmacodynamic Mechanisms via Measurements of Metabolic Flux: Fundamental Concepts and Guiding Principles for Using Stable Isotope TracersNatalie A. Daurio, Sheng-Ping Wang, Ying Chen, Haihong Zhou, David G. McLaren, Thomas P. Roddy, Douglas G. Johns, Denise Milot, Takhar Kasumov, Mark D. Erion, David E. Kelley and Stephen F. PrevisJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 80-91; DOI: https://doi.org/10.1124/jpet.117.241091
Choi, Irene Y.
- You have accessNKTR-181: A Novel Mu-Opioid Analgesic with Inherently Low Abuse PotentialTakahiro Miyazaki, Irene Y. Choi, Werner Rubas, Neel K. Anand, Cherie Ali, Juli Evans, Hema Gursahani, Marlene Hennessy, Grace Kim, Daniel McWeeney, Juergen Pfeiffer, Phi Quach, David Gauvin, Timothy A. Riley, Jennifer A. Riggs, Kathleen Gogas, Jonathan Zalevsky and Stephen K. DobersteinJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 104-113; DOI: https://doi.org/10.1124/jpet.117.243030
Cutolo, Pasquale
- You have accessCXCR4-Specific Nanobodies as Potential Therapeutics for WHIM syndromeRaymond H. de Wit, Raimond Heukers, Hendrik J. Brink, Angela Arsova, David Maussang, Pasquale Cutolo, Beatrijs Strubbe, Henry F. Vischer, Françoise Bachelerie and Martine J. SmitJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 35-44; DOI: https://doi.org/10.1124/jpet.117.242735
D
Daurio, Natalie A.
- You have accessEnhancing Studies of Pharmacodynamic Mechanisms via Measurements of Metabolic Flux: Fundamental Concepts and Guiding Principles for Using Stable Isotope TracersNatalie A. Daurio, Sheng-Ping Wang, Ying Chen, Haihong Zhou, David G. McLaren, Thomas P. Roddy, Douglas G. Johns, Denise Milot, Takhar Kasumov, Mark D. Erion, David E. Kelley and Stephen F. PrevisJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 80-91; DOI: https://doi.org/10.1124/jpet.117.241091
de Wit, Raymond H.
- You have accessCXCR4-Specific Nanobodies as Potential Therapeutics for WHIM syndromeRaymond H. de Wit, Raimond Heukers, Hendrik J. Brink, Angela Arsova, David Maussang, Pasquale Cutolo, Beatrijs Strubbe, Henry F. Vischer, Françoise Bachelerie and Martine J. SmitJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 35-44; DOI: https://doi.org/10.1124/jpet.117.242735
Doberstein, Stephen K.
- You have accessNKTR-181: A Novel Mu-Opioid Analgesic with Inherently Low Abuse PotentialTakahiro Miyazaki, Irene Y. Choi, Werner Rubas, Neel K. Anand, Cherie Ali, Juli Evans, Hema Gursahani, Marlene Hennessy, Grace Kim, Daniel McWeeney, Juergen Pfeiffer, Phi Quach, David Gauvin, Timothy A. Riley, Jennifer A. Riggs, Kathleen Gogas, Jonathan Zalevsky and Stephen K. DobersteinJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 104-113; DOI: https://doi.org/10.1124/jpet.117.243030
DuBois, Debra C.
- You have accessMechanistic Multi—Tissue Modeling of Glucocorticoid-Induced Leucine Zipper Regulation: Integrating Circadian Gene Expression with Receptor-Mediated Corticosteroid PharmacodynamicsVivaswath S. Ayyar, Debra C. DuBois, Richard R. Almon and William J. JuskoJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 45-57; DOI: https://doi.org/10.1124/jpet.117.242990
E
Erion, Mark D.
- You have accessEnhancing Studies of Pharmacodynamic Mechanisms via Measurements of Metabolic Flux: Fundamental Concepts and Guiding Principles for Using Stable Isotope TracersNatalie A. Daurio, Sheng-Ping Wang, Ying Chen, Haihong Zhou, David G. McLaren, Thomas P. Roddy, Douglas G. Johns, Denise Milot, Takhar Kasumov, Mark D. Erion, David E. Kelley and Stephen F. PrevisJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 80-91; DOI: https://doi.org/10.1124/jpet.117.241091
Evans, Juli
- You have accessNKTR-181: A Novel Mu-Opioid Analgesic with Inherently Low Abuse PotentialTakahiro Miyazaki, Irene Y. Choi, Werner Rubas, Neel K. Anand, Cherie Ali, Juli Evans, Hema Gursahani, Marlene Hennessy, Grace Kim, Daniel McWeeney, Juergen Pfeiffer, Phi Quach, David Gauvin, Timothy A. Riley, Jennifer A. Riggs, Kathleen Gogas, Jonathan Zalevsky and Stephen K. DobersteinJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 104-113; DOI: https://doi.org/10.1124/jpet.117.243030
F
Feldser, Heidi G.
- You have accessCharacterization of the Potent, Selective Nrf2 Activator, 3-(Pyridin-3-Ylsulfonyl)-5-(Trifluoromethyl)-2H-Chromen-2-One, in Cellular and In Vivo Models of Pulmonary Oxidative StressJohn G. Yonchuk, Joseph P. Foley, Brian J. Bolognese, Gregory Logan, William E. Wixted, Jen-Pyng Kou, Diana G. Chalupowicz, Heidi G. Feldser, Yolanda Sanchez, Hong Nie, James F. Callahan, Jeffrey K. Kerns and Patricia L. PodolinJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 114-125; DOI: https://doi.org/10.1124/jpet.117.241794
Fichna, Jakub
- You have accessNew Peptide Inhibitor of Dipeptidyl Peptidase IV, EMDB-1 Extends the Half-Life of GLP-2 and Attenuates Colitis in Mice after Topical AdministrationMaciej Salaga, Anna Mokrowiecka, Marta Zielinska, Ewa Malecka-Panas, Radzislaw Kordek, Elzbieta Kamysz and Jakub FichnaJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 92-103; DOI: https://doi.org/10.1124/jpet.117.242586
Foley, Joseph P.
- You have accessCharacterization of the Potent, Selective Nrf2 Activator, 3-(Pyridin-3-Ylsulfonyl)-5-(Trifluoromethyl)-2H-Chromen-2-One, in Cellular and In Vivo Models of Pulmonary Oxidative StressJohn G. Yonchuk, Joseph P. Foley, Brian J. Bolognese, Gregory Logan, William E. Wixted, Jen-Pyng Kou, Diana G. Chalupowicz, Heidi G. Feldser, Yolanda Sanchez, Hong Nie, James F. Callahan, Jeffrey K. Kerns and Patricia L. PodolinJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 114-125; DOI: https://doi.org/10.1124/jpet.117.241794
G
Ganugula, Raghu
- You have accessUrolithin A Mitigates Cisplatin-Induced Nephrotoxicity by Inhibiting Renal Inflammation and Apoptosis in an Experimental Rat ModelMelissa Guada, Raghu Ganugula, Manicka Vadhanam and Majeti N.V. Ravi KumarJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 58-65; DOI: https://doi.org/10.1124/jpet.117.242420
Gauvin, David
- You have accessNKTR-181: A Novel Mu-Opioid Analgesic with Inherently Low Abuse PotentialTakahiro Miyazaki, Irene Y. Choi, Werner Rubas, Neel K. Anand, Cherie Ali, Juli Evans, Hema Gursahani, Marlene Hennessy, Grace Kim, Daniel McWeeney, Juergen Pfeiffer, Phi Quach, David Gauvin, Timothy A. Riley, Jennifer A. Riggs, Kathleen Gogas, Jonathan Zalevsky and Stephen K. DobersteinJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 104-113; DOI: https://doi.org/10.1124/jpet.117.243030
Gogas, Kathleen
- You have accessNKTR-181: A Novel Mu-Opioid Analgesic with Inherently Low Abuse PotentialTakahiro Miyazaki, Irene Y. Choi, Werner Rubas, Neel K. Anand, Cherie Ali, Juli Evans, Hema Gursahani, Marlene Hennessy, Grace Kim, Daniel McWeeney, Juergen Pfeiffer, Phi Quach, David Gauvin, Timothy A. Riley, Jennifer A. Riggs, Kathleen Gogas, Jonathan Zalevsky and Stephen K. DobersteinJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 104-113; DOI: https://doi.org/10.1124/jpet.117.243030
Goody, S. M. G.
- You have accessAssessing the Value of the Zebrafish Conditioned Place Preference Model for Predicting Human Abuse PotentialA. J. Brock, S. M. G. Goody, A. N. Mead, A. Sudwarts, M.O. Parker and C.H. BrennanJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 66-79; DOI: https://doi.org/10.1124/jpet.117.242628
Guada, Melissa
- You have accessUrolithin A Mitigates Cisplatin-Induced Nephrotoxicity by Inhibiting Renal Inflammation and Apoptosis in an Experimental Rat ModelMelissa Guada, Raghu Ganugula, Manicka Vadhanam and Majeti N.V. Ravi KumarJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 58-65; DOI: https://doi.org/10.1124/jpet.117.242420
Gursahani, Hema
- You have accessNKTR-181: A Novel Mu-Opioid Analgesic with Inherently Low Abuse PotentialTakahiro Miyazaki, Irene Y. Choi, Werner Rubas, Neel K. Anand, Cherie Ali, Juli Evans, Hema Gursahani, Marlene Hennessy, Grace Kim, Daniel McWeeney, Juergen Pfeiffer, Phi Quach, David Gauvin, Timothy A. Riley, Jennifer A. Riggs, Kathleen Gogas, Jonathan Zalevsky and Stephen K. DobersteinJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 104-113; DOI: https://doi.org/10.1124/jpet.117.243030
H
Henderson, Colin J.
- Open AccessNovel Pathways of Ponatinib Disposition Catalyzed By CYP1A1 Involving Generation of Potentially Toxic MetabolitesDe Lin, Rumen Kostov, Jeffrey T.-J. Huang, Colin J. Henderson and C. Roland WolfJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 12-19; DOI: https://doi.org/10.1124/jpet.117.243246
Hennessy, Marlene
- You have accessNKTR-181: A Novel Mu-Opioid Analgesic with Inherently Low Abuse PotentialTakahiro Miyazaki, Irene Y. Choi, Werner Rubas, Neel K. Anand, Cherie Ali, Juli Evans, Hema Gursahani, Marlene Hennessy, Grace Kim, Daniel McWeeney, Juergen Pfeiffer, Phi Quach, David Gauvin, Timothy A. Riley, Jennifer A. Riggs, Kathleen Gogas, Jonathan Zalevsky and Stephen K. DobersteinJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 104-113; DOI: https://doi.org/10.1124/jpet.117.243030
Heukers, Raimond
- You have accessCXCR4-Specific Nanobodies as Potential Therapeutics for WHIM syndromeRaymond H. de Wit, Raimond Heukers, Hendrik J. Brink, Angela Arsova, David Maussang, Pasquale Cutolo, Beatrijs Strubbe, Henry F. Vischer, Françoise Bachelerie and Martine J. SmitJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 35-44; DOI: https://doi.org/10.1124/jpet.117.242735
Huang, Jeffrey T.-J.
- Open AccessNovel Pathways of Ponatinib Disposition Catalyzed By CYP1A1 Involving Generation of Potentially Toxic MetabolitesDe Lin, Rumen Kostov, Jeffrey T.-J. Huang, Colin J. Henderson and C. Roland WolfJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 12-19; DOI: https://doi.org/10.1124/jpet.117.243246
I
Ibrahim, Yasmine F.
- You have accessDocetaxel Reverses Pulmonary Vascular Remodeling by Decreasing Autophagy and Resolves Right Ventricular FibrosisYasmine F. Ibrahim, Nataliia V. Shults, Vladyslava Rybka and Yuichiro J. SuzukiJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 20-34; DOI: https://doi.org/10.1124/jpet.117.239921
J
Johns, Douglas G.
- You have accessEnhancing Studies of Pharmacodynamic Mechanisms via Measurements of Metabolic Flux: Fundamental Concepts and Guiding Principles for Using Stable Isotope TracersNatalie A. Daurio, Sheng-Ping Wang, Ying Chen, Haihong Zhou, David G. McLaren, Thomas P. Roddy, Douglas G. Johns, Denise Milot, Takhar Kasumov, Mark D. Erion, David E. Kelley and Stephen F. PrevisJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 80-91; DOI: https://doi.org/10.1124/jpet.117.241091
Jusko, William J.
- You have accessMechanistic Multi—Tissue Modeling of Glucocorticoid-Induced Leucine Zipper Regulation: Integrating Circadian Gene Expression with Receptor-Mediated Corticosteroid PharmacodynamicsVivaswath S. Ayyar, Debra C. DuBois, Richard R. Almon and William J. JuskoJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 45-57; DOI: https://doi.org/10.1124/jpet.117.242990
K
Kamysz, Elzbieta
- You have accessNew Peptide Inhibitor of Dipeptidyl Peptidase IV, EMDB-1 Extends the Half-Life of GLP-2 and Attenuates Colitis in Mice after Topical AdministrationMaciej Salaga, Anna Mokrowiecka, Marta Zielinska, Ewa Malecka-Panas, Radzislaw Kordek, Elzbieta Kamysz and Jakub FichnaJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 92-103; DOI: https://doi.org/10.1124/jpet.117.242586
Kasumov, Takhar
- You have accessEnhancing Studies of Pharmacodynamic Mechanisms via Measurements of Metabolic Flux: Fundamental Concepts and Guiding Principles for Using Stable Isotope TracersNatalie A. Daurio, Sheng-Ping Wang, Ying Chen, Haihong Zhou, David G. McLaren, Thomas P. Roddy, Douglas G. Johns, Denise Milot, Takhar Kasumov, Mark D. Erion, David E. Kelley and Stephen F. PrevisJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 80-91; DOI: https://doi.org/10.1124/jpet.117.241091
Kelley, David E.
- You have accessEnhancing Studies of Pharmacodynamic Mechanisms via Measurements of Metabolic Flux: Fundamental Concepts and Guiding Principles for Using Stable Isotope TracersNatalie A. Daurio, Sheng-Ping Wang, Ying Chen, Haihong Zhou, David G. McLaren, Thomas P. Roddy, Douglas G. Johns, Denise Milot, Takhar Kasumov, Mark D. Erion, David E. Kelley and Stephen F. PrevisJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 80-91; DOI: https://doi.org/10.1124/jpet.117.241091
Kerns, Jeffrey K.
- You have accessCharacterization of the Potent, Selective Nrf2 Activator, 3-(Pyridin-3-Ylsulfonyl)-5-(Trifluoromethyl)-2H-Chromen-2-One, in Cellular and In Vivo Models of Pulmonary Oxidative StressJohn G. Yonchuk, Joseph P. Foley, Brian J. Bolognese, Gregory Logan, William E. Wixted, Jen-Pyng Kou, Diana G. Chalupowicz, Heidi G. Feldser, Yolanda Sanchez, Hong Nie, James F. Callahan, Jeffrey K. Kerns and Patricia L. PodolinJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 114-125; DOI: https://doi.org/10.1124/jpet.117.241794
Kim, Grace
- You have accessNKTR-181: A Novel Mu-Opioid Analgesic with Inherently Low Abuse PotentialTakahiro Miyazaki, Irene Y. Choi, Werner Rubas, Neel K. Anand, Cherie Ali, Juli Evans, Hema Gursahani, Marlene Hennessy, Grace Kim, Daniel McWeeney, Juergen Pfeiffer, Phi Quach, David Gauvin, Timothy A. Riley, Jennifer A. Riggs, Kathleen Gogas, Jonathan Zalevsky and Stephen K. DobersteinJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 104-113; DOI: https://doi.org/10.1124/jpet.117.243030
Kordek, Radzislaw
- You have accessNew Peptide Inhibitor of Dipeptidyl Peptidase IV, EMDB-1 Extends the Half-Life of GLP-2 and Attenuates Colitis in Mice after Topical AdministrationMaciej Salaga, Anna Mokrowiecka, Marta Zielinska, Ewa Malecka-Panas, Radzislaw Kordek, Elzbieta Kamysz and Jakub FichnaJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 92-103; DOI: https://doi.org/10.1124/jpet.117.242586
Kostov, Rumen
- Open AccessNovel Pathways of Ponatinib Disposition Catalyzed By CYP1A1 Involving Generation of Potentially Toxic MetabolitesDe Lin, Rumen Kostov, Jeffrey T.-J. Huang, Colin J. Henderson and C. Roland WolfJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 12-19; DOI: https://doi.org/10.1124/jpet.117.243246
Kou, Jen-Pyng
- You have accessCharacterization of the Potent, Selective Nrf2 Activator, 3-(Pyridin-3-Ylsulfonyl)-5-(Trifluoromethyl)-2H-Chromen-2-One, in Cellular and In Vivo Models of Pulmonary Oxidative StressJohn G. Yonchuk, Joseph P. Foley, Brian J. Bolognese, Gregory Logan, William E. Wixted, Jen-Pyng Kou, Diana G. Chalupowicz, Heidi G. Feldser, Yolanda Sanchez, Hong Nie, James F. Callahan, Jeffrey K. Kerns and Patricia L. PodolinJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 114-125; DOI: https://doi.org/10.1124/jpet.117.241794
L
Lin, De
- Open AccessNovel Pathways of Ponatinib Disposition Catalyzed By CYP1A1 Involving Generation of Potentially Toxic MetabolitesDe Lin, Rumen Kostov, Jeffrey T.-J. Huang, Colin J. Henderson and C. Roland WolfJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 12-19; DOI: https://doi.org/10.1124/jpet.117.243246
Logan, Gregory
- You have accessCharacterization of the Potent, Selective Nrf2 Activator, 3-(Pyridin-3-Ylsulfonyl)-5-(Trifluoromethyl)-2H-Chromen-2-One, in Cellular and In Vivo Models of Pulmonary Oxidative StressJohn G. Yonchuk, Joseph P. Foley, Brian J. Bolognese, Gregory Logan, William E. Wixted, Jen-Pyng Kou, Diana G. Chalupowicz, Heidi G. Feldser, Yolanda Sanchez, Hong Nie, James F. Callahan, Jeffrey K. Kerns and Patricia L. PodolinJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 114-125; DOI: https://doi.org/10.1124/jpet.117.241794
M
Malecka-Panas, Ewa
- You have accessNew Peptide Inhibitor of Dipeptidyl Peptidase IV, EMDB-1 Extends the Half-Life of GLP-2 and Attenuates Colitis in Mice after Topical AdministrationMaciej Salaga, Anna Mokrowiecka, Marta Zielinska, Ewa Malecka-Panas, Radzislaw Kordek, Elzbieta Kamysz and Jakub FichnaJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 92-103; DOI: https://doi.org/10.1124/jpet.117.242586
Maussang, David
- You have accessCXCR4-Specific Nanobodies as Potential Therapeutics for WHIM syndromeRaymond H. de Wit, Raimond Heukers, Hendrik J. Brink, Angela Arsova, David Maussang, Pasquale Cutolo, Beatrijs Strubbe, Henry F. Vischer, Françoise Bachelerie and Martine J. SmitJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 35-44; DOI: https://doi.org/10.1124/jpet.117.242735
McLaren, David G.
- You have accessEnhancing Studies of Pharmacodynamic Mechanisms via Measurements of Metabolic Flux: Fundamental Concepts and Guiding Principles for Using Stable Isotope TracersNatalie A. Daurio, Sheng-Ping Wang, Ying Chen, Haihong Zhou, David G. McLaren, Thomas P. Roddy, Douglas G. Johns, Denise Milot, Takhar Kasumov, Mark D. Erion, David E. Kelley and Stephen F. PrevisJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 80-91; DOI: https://doi.org/10.1124/jpet.117.241091
McWeeney, Daniel
- You have accessNKTR-181: A Novel Mu-Opioid Analgesic with Inherently Low Abuse PotentialTakahiro Miyazaki, Irene Y. Choi, Werner Rubas, Neel K. Anand, Cherie Ali, Juli Evans, Hema Gursahani, Marlene Hennessy, Grace Kim, Daniel McWeeney, Juergen Pfeiffer, Phi Quach, David Gauvin, Timothy A. Riley, Jennifer A. Riggs, Kathleen Gogas, Jonathan Zalevsky and Stephen K. DobersteinJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 104-113; DOI: https://doi.org/10.1124/jpet.117.243030
Mead, A. N.
- You have accessAssessing the Value of the Zebrafish Conditioned Place Preference Model for Predicting Human Abuse PotentialA. J. Brock, S. M. G. Goody, A. N. Mead, A. Sudwarts, M.O. Parker and C.H. BrennanJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 66-79; DOI: https://doi.org/10.1124/jpet.117.242628
Milot, Denise
- You have accessEnhancing Studies of Pharmacodynamic Mechanisms via Measurements of Metabolic Flux: Fundamental Concepts and Guiding Principles for Using Stable Isotope TracersNatalie A. Daurio, Sheng-Ping Wang, Ying Chen, Haihong Zhou, David G. McLaren, Thomas P. Roddy, Douglas G. Johns, Denise Milot, Takhar Kasumov, Mark D. Erion, David E. Kelley and Stephen F. PrevisJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 80-91; DOI: https://doi.org/10.1124/jpet.117.241091
Miyazaki, Takahiro
- You have accessNKTR-181: A Novel Mu-Opioid Analgesic with Inherently Low Abuse PotentialTakahiro Miyazaki, Irene Y. Choi, Werner Rubas, Neel K. Anand, Cherie Ali, Juli Evans, Hema Gursahani, Marlene Hennessy, Grace Kim, Daniel McWeeney, Juergen Pfeiffer, Phi Quach, David Gauvin, Timothy A. Riley, Jennifer A. Riggs, Kathleen Gogas, Jonathan Zalevsky and Stephen K. DobersteinJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 104-113; DOI: https://doi.org/10.1124/jpet.117.243030
Mokrowiecka, Anna
- You have accessNew Peptide Inhibitor of Dipeptidyl Peptidase IV, EMDB-1 Extends the Half-Life of GLP-2 and Attenuates Colitis in Mice after Topical AdministrationMaciej Salaga, Anna Mokrowiecka, Marta Zielinska, Ewa Malecka-Panas, Radzislaw Kordek, Elzbieta Kamysz and Jakub FichnaJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 92-103; DOI: https://doi.org/10.1124/jpet.117.242586
Morrow, A. Leslie
- You have accessEthanol Exposure Regulates Gabra1 Expression via Histone Deacetylation at the Promoter in Cultured Cortical NeuronsJohn Peyton Bohnsack, Vraj K. Patel and A. Leslie MorrowJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 1-11; DOI: https://doi.org/10.1124/jpet.117.242446
N
Nie, Hong
- You have accessCharacterization of the Potent, Selective Nrf2 Activator, 3-(Pyridin-3-Ylsulfonyl)-5-(Trifluoromethyl)-2H-Chromen-2-One, in Cellular and In Vivo Models of Pulmonary Oxidative StressJohn G. Yonchuk, Joseph P. Foley, Brian J. Bolognese, Gregory Logan, William E. Wixted, Jen-Pyng Kou, Diana G. Chalupowicz, Heidi G. Feldser, Yolanda Sanchez, Hong Nie, James F. Callahan, Jeffrey K. Kerns and Patricia L. PodolinJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 114-125; DOI: https://doi.org/10.1124/jpet.117.241794
P
Parker, M.O.
- You have accessAssessing the Value of the Zebrafish Conditioned Place Preference Model for Predicting Human Abuse PotentialA. J. Brock, S. M. G. Goody, A. N. Mead, A. Sudwarts, M.O. Parker and C.H. BrennanJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 66-79; DOI: https://doi.org/10.1124/jpet.117.242628
Patel, Vraj K.
- You have accessEthanol Exposure Regulates Gabra1 Expression via Histone Deacetylation at the Promoter in Cultured Cortical NeuronsJohn Peyton Bohnsack, Vraj K. Patel and A. Leslie MorrowJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 1-11; DOI: https://doi.org/10.1124/jpet.117.242446
Pfeiffer, Juergen
- You have accessNKTR-181: A Novel Mu-Opioid Analgesic with Inherently Low Abuse PotentialTakahiro Miyazaki, Irene Y. Choi, Werner Rubas, Neel K. Anand, Cherie Ali, Juli Evans, Hema Gursahani, Marlene Hennessy, Grace Kim, Daniel McWeeney, Juergen Pfeiffer, Phi Quach, David Gauvin, Timothy A. Riley, Jennifer A. Riggs, Kathleen Gogas, Jonathan Zalevsky and Stephen K. DobersteinJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 104-113; DOI: https://doi.org/10.1124/jpet.117.243030
Podolin, Patricia L.
- You have accessCharacterization of the Potent, Selective Nrf2 Activator, 3-(Pyridin-3-Ylsulfonyl)-5-(Trifluoromethyl)-2H-Chromen-2-One, in Cellular and In Vivo Models of Pulmonary Oxidative StressJohn G. Yonchuk, Joseph P. Foley, Brian J. Bolognese, Gregory Logan, William E. Wixted, Jen-Pyng Kou, Diana G. Chalupowicz, Heidi G. Feldser, Yolanda Sanchez, Hong Nie, James F. Callahan, Jeffrey K. Kerns and Patricia L. PodolinJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 114-125; DOI: https://doi.org/10.1124/jpet.117.241794
Previs, Stephen F.
- You have accessEnhancing Studies of Pharmacodynamic Mechanisms via Measurements of Metabolic Flux: Fundamental Concepts and Guiding Principles for Using Stable Isotope TracersNatalie A. Daurio, Sheng-Ping Wang, Ying Chen, Haihong Zhou, David G. McLaren, Thomas P. Roddy, Douglas G. Johns, Denise Milot, Takhar Kasumov, Mark D. Erion, David E. Kelley and Stephen F. PrevisJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 80-91; DOI: https://doi.org/10.1124/jpet.117.241091
Q
Quach, Phi
- You have accessNKTR-181: A Novel Mu-Opioid Analgesic with Inherently Low Abuse PotentialTakahiro Miyazaki, Irene Y. Choi, Werner Rubas, Neel K. Anand, Cherie Ali, Juli Evans, Hema Gursahani, Marlene Hennessy, Grace Kim, Daniel McWeeney, Juergen Pfeiffer, Phi Quach, David Gauvin, Timothy A. Riley, Jennifer A. Riggs, Kathleen Gogas, Jonathan Zalevsky and Stephen K. DobersteinJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 104-113; DOI: https://doi.org/10.1124/jpet.117.243030
R
Ravi Kumar, Majeti N.V.
- You have accessUrolithin A Mitigates Cisplatin-Induced Nephrotoxicity by Inhibiting Renal Inflammation and Apoptosis in an Experimental Rat ModelMelissa Guada, Raghu Ganugula, Manicka Vadhanam and Majeti N.V. Ravi KumarJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 58-65; DOI: https://doi.org/10.1124/jpet.117.242420
Riggs, Jennifer A.
- You have accessNKTR-181: A Novel Mu-Opioid Analgesic with Inherently Low Abuse PotentialTakahiro Miyazaki, Irene Y. Choi, Werner Rubas, Neel K. Anand, Cherie Ali, Juli Evans, Hema Gursahani, Marlene Hennessy, Grace Kim, Daniel McWeeney, Juergen Pfeiffer, Phi Quach, David Gauvin, Timothy A. Riley, Jennifer A. Riggs, Kathleen Gogas, Jonathan Zalevsky and Stephen K. DobersteinJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 104-113; DOI: https://doi.org/10.1124/jpet.117.243030
Riley, Timothy A.
- You have accessNKTR-181: A Novel Mu-Opioid Analgesic with Inherently Low Abuse PotentialTakahiro Miyazaki, Irene Y. Choi, Werner Rubas, Neel K. Anand, Cherie Ali, Juli Evans, Hema Gursahani, Marlene Hennessy, Grace Kim, Daniel McWeeney, Juergen Pfeiffer, Phi Quach, David Gauvin, Timothy A. Riley, Jennifer A. Riggs, Kathleen Gogas, Jonathan Zalevsky and Stephen K. DobersteinJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 104-113; DOI: https://doi.org/10.1124/jpet.117.243030
Roddy, Thomas P.
- You have accessEnhancing Studies of Pharmacodynamic Mechanisms via Measurements of Metabolic Flux: Fundamental Concepts and Guiding Principles for Using Stable Isotope TracersNatalie A. Daurio, Sheng-Ping Wang, Ying Chen, Haihong Zhou, David G. McLaren, Thomas P. Roddy, Douglas G. Johns, Denise Milot, Takhar Kasumov, Mark D. Erion, David E. Kelley and Stephen F. PrevisJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 80-91; DOI: https://doi.org/10.1124/jpet.117.241091
Rubas, Werner
- You have accessNKTR-181: A Novel Mu-Opioid Analgesic with Inherently Low Abuse PotentialTakahiro Miyazaki, Irene Y. Choi, Werner Rubas, Neel K. Anand, Cherie Ali, Juli Evans, Hema Gursahani, Marlene Hennessy, Grace Kim, Daniel McWeeney, Juergen Pfeiffer, Phi Quach, David Gauvin, Timothy A. Riley, Jennifer A. Riggs, Kathleen Gogas, Jonathan Zalevsky and Stephen K. DobersteinJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 104-113; DOI: https://doi.org/10.1124/jpet.117.243030
Rybka, Vladyslava
- You have accessDocetaxel Reverses Pulmonary Vascular Remodeling by Decreasing Autophagy and Resolves Right Ventricular FibrosisYasmine F. Ibrahim, Nataliia V. Shults, Vladyslava Rybka and Yuichiro J. SuzukiJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 20-34; DOI: https://doi.org/10.1124/jpet.117.239921
S
Salaga, Maciej
- You have accessNew Peptide Inhibitor of Dipeptidyl Peptidase IV, EMDB-1 Extends the Half-Life of GLP-2 and Attenuates Colitis in Mice after Topical AdministrationMaciej Salaga, Anna Mokrowiecka, Marta Zielinska, Ewa Malecka-Panas, Radzislaw Kordek, Elzbieta Kamysz and Jakub FichnaJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 92-103; DOI: https://doi.org/10.1124/jpet.117.242586
Sanchez, Yolanda
- You have accessCharacterization of the Potent, Selective Nrf2 Activator, 3-(Pyridin-3-Ylsulfonyl)-5-(Trifluoromethyl)-2H-Chromen-2-One, in Cellular and In Vivo Models of Pulmonary Oxidative StressJohn G. Yonchuk, Joseph P. Foley, Brian J. Bolognese, Gregory Logan, William E. Wixted, Jen-Pyng Kou, Diana G. Chalupowicz, Heidi G. Feldser, Yolanda Sanchez, Hong Nie, James F. Callahan, Jeffrey K. Kerns and Patricia L. PodolinJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 114-125; DOI: https://doi.org/10.1124/jpet.117.241794
Shults, Nataliia V.
- You have accessDocetaxel Reverses Pulmonary Vascular Remodeling by Decreasing Autophagy and Resolves Right Ventricular FibrosisYasmine F. Ibrahim, Nataliia V. Shults, Vladyslava Rybka and Yuichiro J. SuzukiJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 20-34; DOI: https://doi.org/10.1124/jpet.117.239921
Smit, Martine J.
- You have accessCXCR4-Specific Nanobodies as Potential Therapeutics for WHIM syndromeRaymond H. de Wit, Raimond Heukers, Hendrik J. Brink, Angela Arsova, David Maussang, Pasquale Cutolo, Beatrijs Strubbe, Henry F. Vischer, Françoise Bachelerie and Martine J. SmitJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 35-44; DOI: https://doi.org/10.1124/jpet.117.242735
Strubbe, Beatrijs
- You have accessCXCR4-Specific Nanobodies as Potential Therapeutics for WHIM syndromeRaymond H. de Wit, Raimond Heukers, Hendrik J. Brink, Angela Arsova, David Maussang, Pasquale Cutolo, Beatrijs Strubbe, Henry F. Vischer, Françoise Bachelerie and Martine J. SmitJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 35-44; DOI: https://doi.org/10.1124/jpet.117.242735
Sudwarts, A.
- You have accessAssessing the Value of the Zebrafish Conditioned Place Preference Model for Predicting Human Abuse PotentialA. J. Brock, S. M. G. Goody, A. N. Mead, A. Sudwarts, M.O. Parker and C.H. BrennanJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 66-79; DOI: https://doi.org/10.1124/jpet.117.242628
Suzuki, Yuichiro J.
- You have accessDocetaxel Reverses Pulmonary Vascular Remodeling by Decreasing Autophagy and Resolves Right Ventricular FibrosisYasmine F. Ibrahim, Nataliia V. Shults, Vladyslava Rybka and Yuichiro J. SuzukiJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 20-34; DOI: https://doi.org/10.1124/jpet.117.239921
V
Vadhanam, Manicka
- You have accessUrolithin A Mitigates Cisplatin-Induced Nephrotoxicity by Inhibiting Renal Inflammation and Apoptosis in an Experimental Rat ModelMelissa Guada, Raghu Ganugula, Manicka Vadhanam and Majeti N.V. Ravi KumarJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 58-65; DOI: https://doi.org/10.1124/jpet.117.242420
Vischer, Henry F.
- You have accessCXCR4-Specific Nanobodies as Potential Therapeutics for WHIM syndromeRaymond H. de Wit, Raimond Heukers, Hendrik J. Brink, Angela Arsova, David Maussang, Pasquale Cutolo, Beatrijs Strubbe, Henry F. Vischer, Françoise Bachelerie and Martine J. SmitJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 35-44; DOI: https://doi.org/10.1124/jpet.117.242735
W
Wang, Sheng-Ping
- You have accessEnhancing Studies of Pharmacodynamic Mechanisms via Measurements of Metabolic Flux: Fundamental Concepts and Guiding Principles for Using Stable Isotope TracersNatalie A. Daurio, Sheng-Ping Wang, Ying Chen, Haihong Zhou, David G. McLaren, Thomas P. Roddy, Douglas G. Johns, Denise Milot, Takhar Kasumov, Mark D. Erion, David E. Kelley and Stephen F. PrevisJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 80-91; DOI: https://doi.org/10.1124/jpet.117.241091
Wixted, William E.
- You have accessCharacterization of the Potent, Selective Nrf2 Activator, 3-(Pyridin-3-Ylsulfonyl)-5-(Trifluoromethyl)-2H-Chromen-2-One, in Cellular and In Vivo Models of Pulmonary Oxidative StressJohn G. Yonchuk, Joseph P. Foley, Brian J. Bolognese, Gregory Logan, William E. Wixted, Jen-Pyng Kou, Diana G. Chalupowicz, Heidi G. Feldser, Yolanda Sanchez, Hong Nie, James F. Callahan, Jeffrey K. Kerns and Patricia L. PodolinJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 114-125; DOI: https://doi.org/10.1124/jpet.117.241794
Wolf, C. Roland
- Open AccessNovel Pathways of Ponatinib Disposition Catalyzed By CYP1A1 Involving Generation of Potentially Toxic MetabolitesDe Lin, Rumen Kostov, Jeffrey T.-J. Huang, Colin J. Henderson and C. Roland WolfJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 12-19; DOI: https://doi.org/10.1124/jpet.117.243246
Y
Yonchuk, John G.
- You have accessCharacterization of the Potent, Selective Nrf2 Activator, 3-(Pyridin-3-Ylsulfonyl)-5-(Trifluoromethyl)-2H-Chromen-2-One, in Cellular and In Vivo Models of Pulmonary Oxidative StressJohn G. Yonchuk, Joseph P. Foley, Brian J. Bolognese, Gregory Logan, William E. Wixted, Jen-Pyng Kou, Diana G. Chalupowicz, Heidi G. Feldser, Yolanda Sanchez, Hong Nie, James F. Callahan, Jeffrey K. Kerns and Patricia L. PodolinJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 114-125; DOI: https://doi.org/10.1124/jpet.117.241794
Z
Zalevsky, Jonathan
- You have accessNKTR-181: A Novel Mu-Opioid Analgesic with Inherently Low Abuse PotentialTakahiro Miyazaki, Irene Y. Choi, Werner Rubas, Neel K. Anand, Cherie Ali, Juli Evans, Hema Gursahani, Marlene Hennessy, Grace Kim, Daniel McWeeney, Juergen Pfeiffer, Phi Quach, David Gauvin, Timothy A. Riley, Jennifer A. Riggs, Kathleen Gogas, Jonathan Zalevsky and Stephen K. DobersteinJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 104-113; DOI: https://doi.org/10.1124/jpet.117.243030
Zhou, Haihong
- You have accessEnhancing Studies of Pharmacodynamic Mechanisms via Measurements of Metabolic Flux: Fundamental Concepts and Guiding Principles for Using Stable Isotope TracersNatalie A. Daurio, Sheng-Ping Wang, Ying Chen, Haihong Zhou, David G. McLaren, Thomas P. Roddy, Douglas G. Johns, Denise Milot, Takhar Kasumov, Mark D. Erion, David E. Kelley and Stephen F. PrevisJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 80-91; DOI: https://doi.org/10.1124/jpet.117.241091
Zielinska, Marta
- You have accessNew Peptide Inhibitor of Dipeptidyl Peptidase IV, EMDB-1 Extends the Half-Life of GLP-2 and Attenuates Colitis in Mice after Topical AdministrationMaciej Salaga, Anna Mokrowiecka, Marta Zielinska, Ewa Malecka-Panas, Radzislaw Kordek, Elzbieta Kamysz and Jakub FichnaJournal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 92-103; DOI: https://doi.org/10.1124/jpet.117.242586
In this issue
Advertisement